Mitochondrial disease patient motivations and barriers to participate in clinical trials.
Saved in:
| Title: | Mitochondrial disease patient motivations and barriers to participate in clinical trials. |
|---|---|
| Authors: | Zolkipli-Cunningham Z; Division of Neurology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.; Mitochondrial Medicine Frontier Program, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America., Xiao R; Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America., Stoddart A; Mitochondrial Medicine Frontier Program, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.; Arcadia University, Glenside, Pennsylvania, United States of America.; Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America., McCormick EM; Mitochondrial Medicine Frontier Program, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.; Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America., Holberts A; Rare Diseases Clinical Research Network, Health Informatics Institute, University of South Florida, Tampa, Florida, United States of America., Burrill N; Mitochondrial Medicine Frontier Program, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America., McCormack S; Mitochondrial Medicine Frontier Program, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.; Division of Endocrinology and Diabetes, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America., Williams L; Department of Biostatistics, Mailman School of Public Health, Columbia University Medical Center, New York, New York, United States of America., Wang X; Department of Biostatistics, Mailman School of Public Health, Columbia University Medical Center, New York, New York, United States of America., Thompson JLP; Department of Biostatistics, Mailman School of Public Health, Columbia University Medical Center, New York, New York, United States of America., Falk MJ; Mitochondrial Medicine Frontier Program, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.; Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.; Department of Biostatistics, Mailman School of Public Health, Columbia University Medical Center, New York, New York, United States of America. |
| Source: | PloS one [PLoS One] 2018 May 17; Vol. 13 (5), pp. e0197513. Date of Electronic Publication: 2018 May 17 (Print Publication: 2018). |
| Publication Type: | Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1932-6203 |
|---|---|
| DOI: | 10.1371/journal.pone.0197513 |
